RESUMEN
OBJECTIVES: To evaluate the repositioning accuracy of the implant- and abutment-level impression components (impression abutments and implant scan bodies) and implant abutments (with and without anti-rotational hex index); also, to estimate the tightening torque influence on the positional stability of abutments. METHODS: Seven types of prosthetic components (n = 7) [impression pick-up copings (PC), implant scan bodies (ISB), nonhex and hex titanium base implant abutments (TB H and TB NH), multi-unit impression copings (MU PC), multi-unit implant scan bodies (MU ISB), and multi-unit caps (MU C) (Medentika GmbH)] were tested. For repositioning accuracy tests a coordinate measuring machine (CMM) was used. During assembly 15 Ncm torque for all components was applied. After measurement, only hex and nonhex abutments were torqued to 25 Ncm and their coordinates were again recorded to assess torque influence. The procedure was repeated 7 times for each component. Linear and 3D deviations, angulation to the vertical axis, and axial rotation were calculated. The Kruskal-Wallis test was used to compare the measurements between the groups. A post-hoc test (Mann-Whitney U test) was used for pairwise comparison to determine the influence of the torque (α=0.05). RESULTS: Implant- and abutment-level components used for digital scans showed different positional discrepancies compared to ones used for conventional impressions and ranged from 10 to 37 µm. Hex abutments demonstrated statistically significantly lower 3D deviations (4.4 ± 7.1 µm) compared to nonhex abutments (8.7 ± 6.1 µm). Torque influence was significantly lower for hex abutments than for nonhex abutments. CONCLUSIONS: Repositioning inaccuracies were found in all implant- and abutment-level impression components (impression abutments and implant scan bodies) and all abutments (with and without anti-rotational hex index) tested. Final tightening of the components could cause further positional discrepancies. CLINICAL SIGNIFICANCE: The misfit of the prosthetic components used in conventional and digital workflows stays in the clinically acceptable range. Even when multiple connections and disconnections on the track of the laboratory preparation is needed, it should not have a negative influence for single teeth reconstructions. However, in the complex cases with multiple implants, repetitive repositioning of the prosthetic components may lead to the accumulation of vertical, horizontal and rotational errors leading to the clinical problems with the passive fit of the final framework.
Asunto(s)
Implantes Dentales , Pilares Dentales , Torque , Flujo de TrabajoRESUMEN
Background and Objectives: Congenital ureteral stenosis is one of the leading causes of impaired urinary drainage and subsequent dilatation of the urinary collecting system, known as hydronephrosis or ureterohydronephrosis. The mechanism that leads to obstruction is not clearly known. Multiple studies in rat models have shown increased angiotensin II and TGFß levels in obstructed ureteral tissue. The aim of the study is to investigate the expression of fibrosis-related genes in obstructive and normal ureteral tissue. Material and Methods: It is a monocentric pilot study in which nineteen patients were selected prospectively. 17 patients underwent Hynes-Anderson pyeloplasty due to the PUJO; two patients underwent ureteroneocystostomy due to ureterovesical junction obstruction (UVJO); and six patients were chosen for the control group: five underwent nephrectomies due to the kidney tumor and one underwent upper pole heminephrectomy due to the duplex kidney with normal pyeloureteric junctions in all. Tissue RNA was chemically extracted after freezing the biopsy samples in liquid nitrogen, with cDNA synthesis performed immediately after nucleic acid isolation. qPCR was performed to evaluate the relative expression of Tgfb1, Mmp1, Timp1, Pai1, Ctgf, and Vegfa. Expression levels of the Gapdh and Gpi genes (geometric average) were used to calculate the relative expression of the investigated genes. Outliers were removed prior to calculating confidence intervals for the experimental groups, and a Wilcoxon rank-sum test was performed to determine the statistical significance of the differences. Results: Significant differences between healthy and stenotic tissue samples in Ctgf gene expression levels were observed, with the samples from afflicted tissue showing lower expression. No statistical difference in expression levels of Tgfb1, Timp1, Vegfa, Mmp1, and Pai1 was found. Conclusions: These findings suggest that tissue fibrosis, similar to other tissues and organs, is not the leading cause of stenosis, at least at the moment of surgery. Decreased CTGF expression is indicative of the developmental origin of obstruction.
Asunto(s)
Hidronefrosis , Obstrucción Ureteral , Humanos , Ratas , Animales , Metaloproteinasa 1 de la Matriz/genética , Proyectos Piloto , Constricción Patológica , Obstrucción Ureteral/complicaciones , Obstrucción Ureteral/genética , Obstrucción Ureteral/cirugíaRESUMEN
This is the first case describing vaginal papillomatosis with a fibroepithelial polyp of the vulva in a prepubertal girl and vaginal papillomatosis in her twin sister. Parents contacted pediatric urologist regarding their eight-year-old daughter (twin A), who had a growth next to the external urethral meatus. The girl was referred to a pediatric surgeon. The exophytic 3 cm long structure with necrosis on top was found. After obtaining informed consent from girl parents, pediatric surgeon removed the exophytic structure and perform cystoscopy and vaginoscopy for possible changes in the bladder and vagina. Cystoscopy findings were normal. On vaginoscopy, numerous macroscopic papillomatous structures were identified on the cervix and vaginal walls. Vaginal biopsies were performed on the areas affected by papillomatosis. Histopathologic examination showed a fibroepithelial polyp with a central fibrovascular core covered by squamous epithelium and vaginal squamous papillomatosis. The decision was made to perform vaginoscopy on her twin sister (twin B), too. On vaginoscopy, solitary small vaginal papillomas were also found. In this case manifestation of vaginal papillomatosis in twins might have been influenced by inheritance and the same bacterial and viral environment.
RESUMEN
Introduction: To establish the efficacy of ultrasound (US) combined with urine biomarkers in differentiating patients who require surgical management from those who do not, avoiding invasive investigations. Materials and Methods: From February 2019 to February 2021, all pediatric patients who presented with hydronephrosis were selected for the study. All renal units (RU) were evaluated by US, and fresh frozen voided urine samples were collected at the time of inclusion. Hydronephrosis grade was evaluated by the Society for Fetal Urology (SFU) and an alternative grading system (AGS). Patients who had high-grade hydronephrosis on US were referred to renal scan (RS) or intervention, when there was an increase of dilatation in subsequent follow-up images. Fresh frozen urine from the control group with no history of renal diseases and no renal anomalies on US was collected. We compared differences of US parameters combined with urine biomarkers between surgically and non-surgically managed patients and between the groups of patients when they were stratified by different RS findings and analyzed whether urinary biomarkers give any additional value to US. Instead of the anterior-posterior diameter (APD), we used its ratio with mid-parenchymal thickness. The additional efficacy of biomarkers to US was calculated when the US component was derived to a cumulative APD/mid-parenchymal ratio. Results: Sixty-four patients with hydronephrosis were prospectively included in the study accounting for a total of 81 patient visits and 162 RUs evaluated. A control group of 26 patients was collected. The mean age at inclusion in the hydronephrosis group was 43.7(±45.5) months, and a mean age in a control group was 61.2(±41.3) months. The cumulative APD/mid-parenchymal ratio combined with urinary albumin, ß2 microglobulin (ß2-M), and urinary neutrophil gelatinase-associated lipocalcin may have a better performance in the prediction of surgical intervention than the cumulative APD/mid-parenchymal ratio alone (p = 0.1). The best performance to detect the increased tissue transit time and obstructive curve on RS was demonstrated by the ß2-M creatinine ratio. An increased cumulative APD/mid-parenchymal ratio with biomarkers together had a fairly good sensitivity and specificity for detection of DRF < 40%. Conclusions: According to our data, the APD/mid-parenchymal ratio alone has good efficacy in prediction of surgery and abnormal RS findings especially when combined with urine biomarkers.
RESUMEN
STATEMENT OF PROBLEM: Whether intraoral digital scanners with an integrated shade-taking function can substitute for colorimeters, spectrophotometers, or the visual method to reduce working time is unclear. PURPOSE: The purpose of this clinical study was to evaluate the accuracy of the measurement of tooth shade obtained with an intraoral digital scanner in vivo. MATERIAL AND METHODS: Shades of 120 maxillary anterior teeth were evaluated by using a SpectroShade spectrophotometer (SS) and a TRIOS 3 intraoral digital scanner (T3) on 20 participants. The matching of shade readings between the T3 and SS was used to estimate the accuracy of the T3. The percentage of readings when a difference between the shades obtained by both devices was visually perceptible (ΔE>3.7) was calculated. Each of the 120 teeth was measured 5 times to assess repeatability. RESULTS: The accuracy of the T3 was 53.3% when the color was recorded as a Vita 3D-Master (VM) shade and 27.5% for the Vita Classical (VC) shade guide when the SS was taken as a reference. A visually perceptible color difference was found in 25% (VM) and 50.8% (VC) of situations when the shade was determined with the SS and 48.3% (VM) and 78.3% (VC) with the T3. Repeatability was 92% (VM) and 93.5% (VC) for the SS, and 90.33% (VM) and 87.17% (VC) for the T3. CONCLUSIONS: The findings of this study revealed that the tooth color determined by the T3 does not exactly match that obtained by the SS that additional methods of measuring tooth color are recommended. The accuracy of the T3 was higher when the color was recorded as VM values rather than VC values.
Asunto(s)
Coloración de Prótesis , Diente , Color , Percepción de Color , EspectrofotometríaRESUMEN
Background and Objectives: To determine the value of diuretic ultrasonography for the diagnosis of obstructive hydronephrosis. Materials and Methods: Diuretic enhanced ultrasonography was used routinely as a part of examination of patients with hydronephrosis in our Department. There were 72 patients (42 males, 30 females; aged 2 months to 17 years; median age 7.07 years) with a sonoscopic diagnosis of hydronephrosis included from January 2006 until October 2011. The anteroposterior diameter (AD) of renal pelvis was measured sonoscopically before and at sixty minutes after furosemide injection. A weight-adjusted dose of 1 mg/kg of furosemide was administered intravenously. Results: Patients were operated on if pyeloureteral obstruction was suspected because of low or deteriorating differential renal function, increasing hydronephrosis or symptoms thereof. Hydronephrosis was unilateral in 61 (84.7%) and bilateral in 11 (15.3%) patients. The median AD of pelvis before furosemide injection was 22 mm in operated and 17 mm in non-operated patients (p = 0.005). Sixty minutes after furosemide injection, the AD of pelvis in operated patients was 35.5 mm and 25.8 mm in non-operated-25.8 mm (p < 0.001). Logistic regression model demonstrated that significant factors for surgery were: AD 60 min after furosemide infection and ultrasonographic parenchymal sclerosis. Conclusion: Ultrasound measurement of the AD of renal pelvis 1 h after the injection of furosemide used as an additional investigation can help in predicting obstructive hydronephrosis.
Asunto(s)
Diuréticos/uso terapéutico , Ultrasonografía/normas , Obstrucción Ureteral/diagnóstico , Adolescente , Niño , Preescolar , Femenino , Furosemida/uso terapéutico , Humanos , Hidronefrosis/complicaciones , Hidronefrosis/diagnóstico , Lactante , Masculino , Ultrasonografía/métodos , Ultrasonografía/estadística & datos numéricos , Obstrucción Ureteral/fisiopatologíaRESUMEN
INTRODUCTION: This prospective study investigated the efficacy of a gonadotropin-releasing hormone agonist (LH-RHa) in restoring defective mini-puberty. MATERIALS AND METHODS: Boys with isolated bilateral cryptorchidism and defective mini-puberty were randomly divided into two groups. The "surgery only" group underwent a second orchidopexy without hormonal treatment (control). The "LH-RHa" group received LH-RHa therapy followed by a second orchidopexy. The number of Ad spermatogonia and the total germ cell count per tubule (S/T) were analyzed. RESULTS: Five boys were included in each arm. In the LH-RHa group, the median S/T increased from 0.11 to 0.42, p=0.04. In the surgery only group, the median S/T did not change. In the surgery only group, none of the testes had Ad spermatogonia. In contrast, in the LH-RHa group, all testes completed the transition from gonocytes to Ad spermatogonia (p=0.008). CONCLUSIONS: Treatment with LH-RHa was effective in rescuing defective mini-puberty in boys with bilateral cryptorchidism.
Asunto(s)
Criptorquidismo/tratamiento farmacológico , Hormona Liberadora de Gonadotropina/uso terapéutico , Maduración Sexual , Niño , Humanos , Infertilidad Masculina , Masculino , Estudios ProspectivosRESUMEN
BACKGROUND: Follicle stimulating hormone and testosterone stimulate Sertoli cells to support germ cell function and differentiation. During mini-puberty, when gonadotropin (GnRH) stimulates increases in plasma luteinizing hormone (LH) and testosterone levels, gonocytes are transformed into Ad spermatogonia. In cryptorchidism, impaired gonadotropin secretion during mini-puberty results in insufficient LH and testosterone secretion, impaired gonocyte transition to Ad spermatogonia, and perturbed Sertoli cell proliferation. Treatment with a gonadotropin-releasing hormone agonist (GnRHa/Buserelin) induced gonocytes to differentiate into Ad spermatogonia and rescued fertility. The present study evaluated the impact of low LH secretion on Sertoli cell function by comparing differential gene expression data between testes with low LH that lacked Ad spermatogonia (Ad-) and testes that completed mini-puberty (Ad+). Furthermore, we analyzed changes in the transcription of selected Sertoli cell specific genes in response to GnRHa treatment. RESULTS: Ad- testes showed reduced expression of nine out of 40 selected Sertoli cell specific genes compared to Ad+ testes. GnRHa treatment repressed most of the Sertoli cell specific genes, including the inhibins, but it increased the expression of genes that regulate apoptosis (FASLG) and proliferation (GDNF). CONCLUSIONS: Impaired-minipuberty with decreased LH and testosterone levels affected Ad and Sertoli cell development through positive and negative regulation of morphoregulatory and apoptotic genes. GnRHa treatment had a repressive effect on most Sertoli cell specific genes, which suggested that Sertoli cells underwent a cellular rearrangement. We propose that gonadotropin-dependent increases in FASLG and GDNF expression drove Sertoli cell proliferation and germ cell self-renewal and supported the transition of gonocytes to Ad spermatogonia, independent of inhibins.
CONTEXTE: L'hormone folliculostimulante et la testostérone stimulent les cellules de Sertoli pour soutenir la fonction et la différentiation des cellules germinales. Pendant la minipuberté, lorsque la gonadotrophine (GnRH) stimule les augmentations des taux plasmatiques d'hormone lutéinisante (LH) et de testostérone, les gonocytes sont transformés en spermatogonies Ad. Dans la cryptorchidie, une sécrétion altérée de gonadotrophine lors de la minipuberté entraine une sécrétion insuffisante de LH et de testostérone, une altération de la transition des gonocytes en spermatogonies Ad, et une perturbation de la prolifération des cellules de Sertoli. Un traitement par agoniste de la gonadolibérine (GnRHa/Buserelin) induit une différenciation des gonocytes en spermatogonies Ad et sauvegarde la fertilité.Cette étude a évalué l'impact d'un taux de LH bas sur la fonction des cellules de Sertoli en comparant les données d'expression différentielle de gènes entre des testicules avec LH basse qui sont dépourvus de spermatogonies Ad (Ad-) et des testicules qui ont fini la minipuberté (Ad+). En outre, la réponse au traitement par GnRHa a été analysée par les modifications de la transcription de gènes sélectionnés pour être spécifiques de la cellule de Sertoli. RÉSULTATS: Les testicules Ad- présentent une expression réduite de 9 des 40 gènes sélectionnés pour être spécifiques de la cellule de Sertoli par comparaison aux testicules Ad+. Le traitement par GnRHa a réprimé l'expression de la plupart des gènes spécifiques de la cellule de Sertoli, y compris les inhibines, mais a augmenté l'expression de gènes qui régulent l'apoptose (FASLG) et la prolifération (GDNF). CONCLUSIONS: Une minipuberté altérée par des taux diminués de LH et de testostérone affecte le développement des spermatogonies Ad et des cellules de Sertoli par une régulation positive et négative de gènes morphorégulateurs et apoptotiques. Le traitement par GnRHa a un effet inhibiteur sur la plupart des gènes spécifiques de la cellule de Sertoli, ce qui suggère que les cellules de Sertoli subissent un réarrangement cellulaire. Nous proposons que les augmentations gonadotrophine-dépendantes de l'expression de FASLG et de GDNF dirigent la prolifération des cellules de Sertoli et l'auto-renouvèlement des cellules germinales, et qu'elles sont le support de la transition gonocytes vers spermatogonies Ad, indépendante des inhibines.
RESUMEN
Defective mini-puberty results in insufficient testosterone secretion that impairs the differentiation of gonocytes into dark-type (Ad) spermatogonia. The differentiation of gonocytes into Ad spermatogonia can be induced by administration of the gonadotropin-releasing hormone agonist, GnRHa (Buserelin, INN)). Nothing is known about the mechanism that underlies successful GnRHa treatment in the germ cells. Using RNA-sequencing of testicular biopsies, we recently examined RNA profiles of testes with and without GnRHa treatment. Here, we focused on the expression patterns of known gene markers for gonocytes and spermatogonia, and found that DMRTC2, PAX7, BRACHYURY/T, and TERT were associated with defective mini-puberty and were responsive to GnRHa. These results indicate novel testosterone-dependent genes and provide valuable insight into the transcriptional response to both defective mini-puberty and curative GnRHa treatment, which prevents infertility in man with one or both undescended (cryptorchid) testes.
RESUMEN
It has been known for many years that boys with unilateral or bilateral undescended testis (cryptorchidism) tend to have a low IQ, and those who belong to the high infertility risk (HIR) group perform less well at school than low infertility risk (LIR) patients. However, the molecular biological processes underlying this phenomenon are not understood. In this study, we report the outcome of testicular RNA profiling for genes involved in long-term memory formation. We analyzed the histology and the transcriptome of testicular biopsies from bilateral HIR cryptorchid boys, comparing those who received GnRHa treatment for 6 months after the first surgery with those who did not receive GnRHa before the second surgery. We found that GnRHa treatment alters the testicular mRNA levels of neuronal genes that are involved in long-term memory and testosterone synthesis. These data highlight a possible molecular link between cryptorchidism, impaired mini-puberty, and diminished cognitive functions. Our results are consistent with the hypothesis that hypogonadotropic hypogonadism in cryptorchid boys with altered mini-puberty may affect neuronal genes important for memory and learning, which could help explaining the negative correlation between cryptorchidism and intellectual abilities.
Asunto(s)
Criptorquidismo/tratamiento farmacológico , Criptorquidismo/genética , Hormona Liberadora de Gonadotropina/análogos & derivados , Memoria a Largo Plazo/efectos de los fármacos , Testículo/metabolismo , Preescolar , Regulación de la Expresión Génica/efectos de los fármacos , Hormona Liberadora de Gonadotropina/farmacología , Hormona Liberadora de Gonadotropina/uso terapéutico , Humanos , Lactante , Infertilidad Masculina/genética , Masculino , ARN Mensajero/genética , ARN Mensajero/metabolismo , Análisis de Secuencia de ARN , Testículo/efectos de los fármacosRESUMEN
The gonadotropin-releasing hormone agonist (GnRHa; Buserelin) rescues fertility during adulthood in the majority of high infertility risk cryptorchid boys presenting with defective mini-puberty. However, the molecular events governing this effect are not understood. We report the outcome of an RNA profiling analysis of testicular biopsies from 4 operated patients who were treated with GnRHa for 6 months versus 3 operated controls who were not treated. GnRHa induces a significant transcriptional response, including protein-coding genes involved in pituitary development, the hypothalamic-pituitary-gonadal axis, and testosterone synthesis. Furthermore, we observed an increased abundance of long noncoding RNAs (lncRNAs) participating in epigenetic processes, including AIRN, FENDRR, XIST, and HOTAIR. These data are consistent with the hypothesis that hypogonadotropic hypogonadism in boys with altered mini-puberty is the consequence of a profoundly altered gene expression program involving protein-coding genes and lncRNAs. Our results point to molecular mechanisms that underlie the ability of GnRHa to rescue fertility.
Asunto(s)
Criptorquidismo/tratamiento farmacológico , Criptorquidismo/genética , Fertilidad/genética , Hormona Liberadora de Gonadotropina/uso terapéutico , Sistema Hipotálamo-Hipofisario/patología , Testosterona/metabolismo , Preescolar , Criptorquidismo/cirugía , Fertilidad/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Hormona Liberadora de Gonadotropina/farmacología , Humanos , Lactante , Masculino , Hipófisis/efectos de los fármacos , Hipófisis/crecimiento & desarrollo , Mapas de Interacción de Proteínas/efectos de los fármacos , ARN Largo no Codificante/genética , ARN Largo no Codificante/metabolismo , Testosterona/biosíntesisRESUMEN
The whole genome RNA profiling of testicular biopsies by DNA strand-specific RNA sequencing was examined to determine a potential causative role of isolated congenital cryptorchidism in azoospermia and/or infertility in the context of our previously published GeneChip data. Cryptorchid patients, aged 7 months to 5 years and otherwise healthy, were enrolled in this prospective study. During surgery, testicular tissue biopsies were obtained for histological examination and RNA sequencing. Fifteen patients were selected based on the histological results and were divided into 2 groups. Seven were classified as belonging to the high infertility risk (HIR) and 8 to the low infertility risk (LIR) group. Cryptorchid boys in the HIR group lacked transformation of gonocytes into Ad spermatogonia due to impaired mini-puberty. This group of patients will be infertile despite successful surgery. The new important finding was a decreased PROK2, CHD7, FGFR1, and SPRY4 gene expression in the HIR group. Furthermore, identification of multiple differences in gene expression between HIR and LIR groups underscores the importance of an intact hypothalamic-pituitary-gonadal axis for fertility development. Our RNA profiling data strongly support the theory that in the HIR group of cryptorchid boys insufficient PROK2/CHD7/FGFR1/SPRY4 gene expression induces deficient LH secretion, resulting in impaired mini-puberty and infertility. We therefore recommend hormonal treatment for this cohort of cryptorchid boys with defective mini-puberty following a seemingly successful orchidopexy.
Asunto(s)
Criptorquidismo/metabolismo , Hipogonadismo/metabolismo , Hipogonadismo/fisiopatología , Pubertad/fisiología , Azoospermia/genética , Azoospermia/metabolismo , Azoospermia/fisiopatología , Preescolar , Criptorquidismo/genética , Criptorquidismo/fisiopatología , ADN Helicasas/genética , ADN Helicasas/metabolismo , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Hormonas Gastrointestinales/genética , Hormonas Gastrointestinales/metabolismo , Humanos , Hipogonadismo/genética , Lactante , Infertilidad Masculina/genética , Infertilidad Masculina/metabolismo , Péptidos y Proteínas de Señalización Intracelular/genética , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Masculino , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Neuropéptidos/genética , Neuropéptidos/metabolismo , Estudios Prospectivos , Pubertad/genética , Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos/genética , Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos/metabolismo , Espermatogonias/metabolismo , Espermatogonias/fisiologíaRESUMEN
INTRODUCTION: A transient increase in gonadotropins and testosterone during mini-puberty causes gonocytes to differentiate into Ad spermatogonia, which establish male germ cell memory and male-specific DNA methylation pathways. Over half of patients with unilateral cryptorchidism and the majority of patients with bilateral cryptorchidism display an abnormal spermiogram, which indicates that unilateral cryptorchidism is a bilateral disease; therefore, it represents a serious andrological problem. The aim of this study was to evaluate relationships between hormonal parameters and testicular biopsy findings in boys with cryptorchidism. METHOD: Seventy-one boys (median age 15 months; range 7-65 months) who underwent orchidopexy (24% had bilateral cryptorchidism) were tested for serum LH, FSH, and inhibin B. With ipsilateral testis biopsy histology, we determined the tubular fertility index (TFI), Ad spermatogonia counts, and Ad/tubular index (Ad/T). We compared age groups (<18 vs. >18 months old); groups with and without Ad spermatogonia; groups with unilateral and bilateral cryptorchidism; and extreme groups with high infertility risk (HIR; n = 12; TFI <0.2; Ad/T = 0) and low infertility risk (LIR; n = 9; TFI >0.9; Ad/T>0.02). RESULTS: Of the specimens, 38% had no Ad spermatogonia. Age was significantly negatively correlated with TFI and Ad/T, but positively correlated with FSH. Median LH values were significantly higher in LIR than in HIR groups. Unilateral and bilateral cryptorchidism showed similar TFI, Ad/T, and hormone concentrations. The areas under ROC curves for FSH, LH, and inhibin B (0.66, 0.601, and 0.599, respectively) showed low diagnostic value for predicting HIR (no Ad spermatogonia). CONCLUSION: Our observation of lower plasma LH levels in the group with the most pronounced testicular pathology was the opposite of what we would have expected if testicular pathological changes were caused by a primary gonadal defect. Therefore, low plasma LH levels in the HIR group confirmed the notion that this group of patients with cryptorchidism had hypogonadotropic hypogonadism. The estimated incidence of defective mini-puberty in boys with cryptorchidism could be as high as 50%. Testicular biopsies from boys with cryptorchidism lacked Ad spermatogonia. Fertility parameters worsened with age. Significantly lower basal LH in the HIR group indicated hypogonadotropic hypogonadism. Serum hormone levels could not predict histological biopsy findings.
Asunto(s)
Criptorquidismo/sangre , Criptorquidismo/patología , Hormona Folículo Estimulante/sangre , Inhibinas/sangre , Hormona Luteinizante/sangre , Testículo/patología , Testículo/fisiopatología , Biopsia , Niño , Preescolar , Criptorquidismo/fisiopatología , Humanos , Lactante , Masculino , Estudios ProspectivosRESUMEN
HC related to BK virus replication might be a severe complication following allogeneic HSCT. There are no clearly defined treatment guidelines in pediatric population. The data on the effectiveness of ICI to manage severe bleeding in children are very limited. We report our experience of intravesical cidofovir in four children, 6-15 yr of age, to manage grade III-IV BK virus-associated HC. Three of four children had high CSA serum level prior to developing cystitis. Intravesical instillations of cidofovir resulted only in temporal relief of bleeding. After immune suppression was withdrawn or tapered, intravesical instillations of formalin solution had to be undertaken to abort severe bleeding. We concluded that intravesical cidofovir alone did not appear to be sufficiently effective in case of severe HC, necessitating complimentary procedures to stop macrohematuria.
Asunto(s)
Cistitis/tratamiento farmacológico , Citosina/análogos & derivados , Organofosfonatos/administración & dosificación , Infecciones por Polyomavirus/tratamiento farmacológico , Administración Intravesical , Adolescente , Antivirales/administración & dosificación , Virus BK/inmunología , Niño , Cidofovir , Cistitis/etiología , Citosina/administración & dosificación , Femenino , Formaldehído/administración & dosificación , Enfermedad Injerto contra Huésped , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Trasplante de Células Madre Hematopoyéticas/métodos , Hemorragia/tratamiento farmacológico , Hemorragia/etiología , Humanos , Sistema Inmunológico , Masculino , Reacción en Cadena de la Polimerasa , Infecciones por Polyomavirus/etiología , Factores de TiempoRESUMEN
BACKGROUND: Increasing evidence of progressive damage to germ cell development in boys with cryptorchidism suggests recommending surgery until one year of age. However, despite early and successful orchidopexy, cryptorchid boys with impaired mini-puberty will suffer from infertility. We reviewed changes in the timing of surgery during the past decade and the incidence of unilateral cryptorchid boys with defective mini-puberty. METHODS: Medical registries were reviewed for all patients who were operated on for cryptorchidism at the main pediatric urological center of the country. The ages of surgery in cases of unilateral cryptorchidism were compared between the years 2000-2001 and 2012-2013. A high risk of infertility was considered when no Ad spermatogonia were found. Two groups were compared: group I--operated on until the age of 1.5 years and group II--older than 1.5 years. RESULTS: The average age at operation decreased from 5.3 to 4.1 years. Forty-six biopsies in boys with unilateral cryptorchidism were made during orchidopexy on undescended testicles. Overall, 44% in group I and 50 % in group II (p > 0.05) had no Ad spermatogonia. CONCLUSIONS: The average age of operation for cryptorchidism has decreased, but remains far above the recommended age. The high prevalence of histologically proven risk of infertility underscores the necessity of more education regarding the importance of earlier surgery and the research on hormonal prevention of infertility.